The Research Council withdrew its financial support for Norvax’s Norwegian vaccine factory. The council believes the company does not have enough expertise for the project.
The support of NOK 16 million was to be used for a research collaboration project with Sintef on the development of vaccine technology.
The Research Council of Norway (NFR) has now withdrawn the financial support, the newspaper Morgenbladet writes.
The council believes that Norvax does not have the necessary competence to carry out the project. They also believe that Norvax has not met the requirements to clarify matters related to research work and the financials, according to the newspaper.
After several key people in Norvax left this summer, the company tried to replace the expertise with British consultants, who, according to the Research Council’s own investigations, were not aware of the roles they had been assigned in Norvax’s plans.
Thus, the processing of the cases concluded that Norvax provided “misleading information to the Research Council.”
In a comment in the newspaper, Norvax’s Peter A. Jensen wrote that the company has never intentionally provided misleading information to anyone. The company has appealed the Research Council’s decision.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at [email protected]
Be the first to comment on "Research Council withdraws its support to a Norvax vaccine factory in Norway"